<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>377</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15315970</PubmedId>
            <Abstract>HIV-1-associated thrombocytopenia (HIV-1-ITP) is a common complication of HIV-1 infection, frequently caused by increased peripheral platelet destruction mediated by antiplatelet antibodies (Abs) and/or platelet-bound immune complexes. Little is known about the specificity of the antiplatelet Abs at a molecular level. Here, we used immunoglobulin G (IgG) phage-display libraries generated from 3 HIV-1-ITP patients to isolate a large panel of human monoclonal antiplatelet Abs by selection on unfixed platelets. The platelet antigen recognized by all the cloned Abs was identified to be the talin head domain (talin-H), a cleavage product of talin that can be generated by platelet activation or HIV-1 protease. Talin-H was found in HIV-1-ITP-circulating immune complexes, and antitalin Abs were detected in HIV-1-ITP sera but not in controls. The cloned anti-talin-H IgGs were highly somatically mutated, indicative of an antigen-driven, affinity-matured response. These findings suggest that talin-H Ab may be a marker of HIV-1-ITP elicited due to exposure of immunodominant epitopes on talin-H as a result of a disease-related process. Abs to talin-H and related immune complexes (ICs) may contribute to HIV-1-ITP.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>4054-62</ArticlePages>
            <ArticleTitle>Identification of talin head domain as an immunodominant epitope of the antiplatelet antibody response in patients with HIV-1-associated thrombocytopenia.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Koefoed</LastName>
                    <ForeName>Klaus</ForeName>
                </Author>
                <Author>
                    <LastName>Ditzel</LastName>
                    <ForeName>Henrik J</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Immunology, The Scripps Research Institute, La Jolla, CA, USA.</Affiliations>
            <ArticleChemicalList>Epitopes;Immunoglobulin Fab Fragments;Immunoglobulin G;Talin</ArticleChemicalList>
            <ArticleMeshHeadingsList>Acquired Immunodeficiency Syndrome(blood; complications; immunology); Amino Acid Sequence; Antibody Formation; Blood Platelets(immunology); Epitopes(immunology); HIV-1; Humans; Immunoglobulin Fab Fragments(chemistry; immunology); Immunoglobulin G(blood); Molecular Sequence Data; Reference Values; Talin(chemistry; immunology); Thrombocytopenia(etiology; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>104</Volume>
                <Issue>13</Issue>
                <Title>Blood</Title>
                <Issn>1528-0020</Issn>
                <MedlineTa>Blood</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>GPIIIa-49-66 peptide</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>CAPESIEFPVSEARVLED</LinearSequence>
                        <StartingPosition>75</StartingPosition>
                        <EndingPosition>92</EndingPosition>
                        <SourceMolecule>
                            <IedbAccession>SRC300</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Materials and Methods</LocationOfData>
                <EpitopeId>6015</EpitopeId>
                <ReferenceStartingPosition>49</ReferenceStartingPosition>
                <ReferenceEndingPosition>66</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>Mature chain begins at residue 27 of precursor.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1B</LocationOfData>
                        <BCellId>13983</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Occurrence of infectious disease</InVivoProcessType>
                                <DiseaseState>DOID:526</DiseaseState>
                                <DiseaseStage>Unknown</DiseaseStage>
                                <ImmunogenObject>
                                    <EpitopeRelation>Other</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11676</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>3</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Serum Abs to the immunodominant epitope, GPIIIA, in patients with clinical signs of HIV-1-associated thrombocytopenia were measured.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-GPIIIa Ab</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>GPIIIa-49-66 peptide</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>CAPESIEFPVSEARVLED</LinearSequence>
                                        <StartingPosition>75</StartingPosition>
                                        <EndingPosition>92</EndingPosition>
                                        <SourceMolecule>
                                            <IedbAccession>SRC300</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

